In vitro activity of new antimicrobial agents againstPseudomonas aeruginosa isolates from cystic fibrosis patients
Letters to the Editor
- 19 Downloads
KeywordsInternal Medicine Cystic Fibrosis Antimicrobial Agent Cystic Fibrosis Patient Vitro Activity
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
- 1.Scribner, R. K., Marks, M. I., Weber, A. H., Tarpay, M. M., Welch, D. F.: Activities of variousβ-lactams and aminoglycosides, alone and in combination, against isolates ofPseudomonas aeruginosa from patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy 1982, 21: 939–943.PubMedGoogle Scholar
- 6.Aronoff, S. C., Klinger, J. D.: In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistantPseudomonas aeruginosa andPseudomonas cepacia isolates from children with cystic fibrosis. Antimicrobial Agents and Chemotherapy 1984, 25: 279–280.PubMedGoogle Scholar
© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1987